isaac
lindenmann
first
recogn
potenti
solubl
probabl
cellderiv
factor
combat
influenza
viru
infect
name
factor
interferon
ifn
latin
interferr
interfer
sinc
three
subgroup
ifn
defin
primarili
differenti
receptor
usag
group
type
ifn
type
iii
ifn
compris
larg
agent
directli
limit
pathogen
spread
improv
cellular
counter
measur
sole
type
ii
ifn
mainli
implic
modul
innat
also
adapt
immun
respons
accordingli
type
iii
ifn
key
signal
molecul
viral
control
lack
signal
pathway
result
increas
viral
load
diseas
sever
still
accumul
evid
lack
antivir
respons
also
unbalanc
overshoot
activ
ifn
contribut
exagger
inflammatori
reaction
tissu
injuri
reduc
prolif
capac
thu
enhanc
diseas
sever
tabl
especi
viral
infect
effect
track
ifn
signal
gener
specif
exagger
product
key
effector
ifnstimul
gene
isg
promin
exampl
tnfrelat
apoptosisinduc
ligand
trail
display
ambival
role
viral
infect
tabl
wherea
first
identifi
factor
produc
immun
cell
nonrespiratori
infect
trail
especi
well
studi
influenza
viru
iav
infect
releas
high
amount
bone
marrowderiv
macrophag
upon
pathogenassoci
molecular
pattern
pamp
recognit
type
ifn
product
macrophagereleas
solubl
trail
also
membranebound
cellassoci
trail
act
via
distinct
receptor
infect
also
noninfect
neighbor
cell
viral
infect
preliminari
role
drive
infect
cell
apoptosi
limit
viru
spread
howev
studi
perform
within
last
decad
demonstr
trail
antivir
activ
seem
outweigh
function
structur
damag
induc
infect
also
bystand
cell
uninfect
cell
alveolar
epithelium
process
relev
promot
viral
diseas
progress
implic
bacteri
superinfect
probabl
also
chronic
diseas
recognit
ambival
role
ifndriven
signal
vivo
first
import
step
better
understand
diseas
progress
envis
novel
treatment
option
primari
viral
respiratori
infect
target
distinct
hostderiv
signal
mediat
trail
commonli
accept
concept
janeway
alreadi
propos
activ
toward
invad
pathogen
mount
upon
recognit
pamp
pamp
evolutionari
conserv
biomolecul
protein
lipid
nitrogen
base
sugar
complex
biomolecul
lipoglycan
essenti
surviv
given
pathogen
pamp
recogn
distinct
pattern
recognit
receptor
prr
germlin
encod
show
high
evolutionari
conserv
first
recogn
probabl
intens
studi
famili
prr
tolllik
receptor
tlr
review
mogensen
leifer
medvedev
viral
infect
host
cell
membraneloc
tlr
detect
viral
envelop
protein
endosom
tlr
nucleic
acid
sensor
initi
signal
transduct
cascad
lead
ifn
product
figur
tlr
activ
result
either
myeloid
differenti
factor
tirdomaincontain
adaptor
proteininduc
trif
recruit
trigger
variou
downstream
signal
event
eventu
lead
ifn
regulatori
factor
irf
nuclear
transloc
well
map
kinas
activ
protein
activ
similar
endosom
tlr
cytosol
retino
acidinduc
gene
rig
ilik
receptor
rlr
special
recogn
viral
nucleic
acid
content
central
prr
relev
mount
antivir
respons
provid
resist
rna
eg
orthomyxovirus
dna
eg
reovirus
virus
review
ref
melanoma
differentiationassoci
gene
rigi
recogn
dsrna
rna
synthet
analog
dsrna
polyi
c
drive
dimer
mitochondriaassoci
adaptor
protein
promot
stimul
also
name
mav
visa
cardif
subsequ
activ
cascad
includ
tradd
tnf
receptor
type
death
domain
protein
tnf
receptorassoci
factor
tank
traf
famili
memberassoci
activ
induc
phosphoryl
result
type
ifn
product
third
rlr
far
primarili
implic
regul
rigi
cofactor
howev
recent
studi
stone
et
al
demonstr
novel
nonredund
independ
role
west
nile
viru
infect
anoth
class
prr
nucleotid
oligomer
domain
nod
like
receptor
nlr
mainli
implic
bacteri
recognit
still
sever
nlr
activ
well
upon
viru
infect
especi
known
recogn
rna
differ
virus
includ
hepat
c
viru
measl
viru
influenza
vesicular
stomat
viru
vsv
result
inflammasom
format
activ
addit
viru
infect
sens
also
structur
divers
group
viral
rna
dna
sensor
resid
cytoplasm
includ
cyclic
synthas
synthes
second
messeng
cgamp
cgamp
turn
activ
stimul
ifn
gene
sting
tankbind
kinas
trigger
ifn
product
moreov
sting
act
prr
implic
dna
viru
recognit
includ
hsv
adenoviru
vaccinia
viru
papilloma
viru
sens
retrovir
hybrid
rna
virus
activ
rigi
anoth
cytosol
nucleic
acid
sensor
pkr
well
known
phosphoryl
eukaryot
initi
factor
respons
viral
dsrna
phosphoryl
result
deactiv
host
translat
shutoff
limit
viral
replic
note
inhibit
protein
synthesi
contribut
induct
furthermor
pkr
implic
effici
type
ifn
activ
respons
dsrna
least
addit
type
ifn
also
type
iii
ifn
exert
antivir
activ
wide
express
viral
recognit
produc
cell
type
includ
epitheli
endotheli
fibroblast
polymorphonuclear
cell
review
ref
like
type
ifn
type
iii
ifn
induc
viral
infect
prr
rigi
well
reli
activ
transcript
activ
includ
observ
initi
led
conclus
type
type
iii
ifn
compris
two
complet
redund
system
induc
isg
respons
pamp
recognit
howev
recent
data
suggest
distinct
select
mechan
either
type
type
iii
ifn
express
specif
induc
type
ifn
locat
peroxisom
membran
instead
mitochondri
membran
respons
rigi
activ
reoviru
sendai
viru
dengu
viru
challeng
interestingli
type
iii
ifn
induct
larg
independ
toward
transloc
facilit
instantan
induct
viral
recognit
highlight
import
immedi
factor
drive
innat
microbi
defens
mechan
releas
ifn
upon
pathogen
recognit
highli
conserv
teleost
fish
insect
prepar
surround
cell
well
host
defens
invad
threat
wherea
often
highlevel
ifn
product
reli
special
sentinel
cell
macrophag
dendrit
cell
dc
mostli
cell
multicellular
organ
abl
respond
least
one
type
ifn
express
respect
receptor
receptor
bind
induc
signal
transduct
cascad
reli
janu
kinas
jak
signal
transduc
activ
transcript
stat
result
effici
transcript
plethora
differ
isg
infect
well
bystand
cell
ifn
engag
classic
canon
signal
transduct
cascad
employ
jakstat
molecul
bind
respect
receptor
herein
type
ifn
ligat
common
heterodimer
receptor
consist
receptor
ifnar
subunit
wherea
type
iii
ifn
act
via
receptor
receptor
heterodim
date
report
restrict
express
epitheli
cell
type
ifn
signal
ifnar
engag
lead
activ
receptorassoci
protein
tyrosin
kinas
tyrosin
kinas
follow
recruit
reposit
alreadi
associ
elsewis
latent
cytoplasmat
transcript
factor
consequ
phosphoryl
conserv
tyrosin
residu
disassembl
undergo
conform
chang
enabl
heterodimer
well
exposur
nuclear
local
sequenc
subsequ
heterodim
transloc
nucleu
interact
form
trimer
ifnstimul
factor
bind
cognat
dna
sequenc
ifnstimul
respons
element
isr
final
lead
isg
induct
also
type
iii
ifn
interact
receptor
complex
trigger
heterodimer
nuclear
transloc
assembl
interferon
signal
result
induct
isg
evok
differ
cellular
respons
viral
infect
infect
well
noninfect
cell
includ
direct
antivir
immunemodulatori
cell
deathinduc
effect
enabl
immedi
robust
respons
pathogen
challeng
mani
isg
directli
interfer
viral
replic
intracellular
level
wellstudi
exampl
antivir
isg
compris
ifninduc
transmembran
protein
ifitm
effect
iav
west
nile
viru
dengu
viru
infect
myxoviru
resist
protein
mxa
interfer
vsv
mrna
product
bind
iav
nucleocapsid
prevent
nuclear
transloc
viral
genet
materi
synthas
oa
activ
rnase
l
trigger
viral
rna
degrad
prr
pkr
besid
activ
ifn
respons
major
impact
viral
protein
translat
inhibit
recent
identifi
isg
includ
plasminogen
activ
inhibitor
block
iav
infect
inhibit
glycoprotein
cleavag
execut
extracellular
airway
proteas
antivir
limit
iav
viral
replic
via
exonucleas
activ
like
interf
viral
np
accordingli
ifn
pretreat
usual
result
establish
antivir
state
limit
viral
replic
spread
start
infect
thu
favor
milder
diseas
outcom
pretreat
demonstr
limit
viral
spread
season
iav
strain
thu
decreas
morbid
mortal
mice
guinea
pig
well
ferret
shown
studi
tumpey
et
al
effect
attribut
earli
induct
antivir
isg
includ
mxa
importantli
type
ifn
pretreat
also
dampen
earli
replic
highli
pathogen
avian
influenza
ferret
also
respiratori
syncyti
viru
rsv
infect
treatment
recombin
result
significantli
decreas
lung
viral
titer
alveolar
inflammatori
cell
accumul
clinic
diseas
rsvinfect
mice
addit
respiratori
infect
caus
emerg
coronavirus
cov
amelior
type
ifn
pretreat
strategi
vivo
macaqu
model
macaca
fasciculari
sever
acut
respiratori
syndrom
sar
cov
infect
could
demonstr
pretreat
pegyl
significantli
diminish
cov
replic
excret
result
reduc
pulmonari
damag
macaqu
also
serv
preclin
model
middl
east
respiratori
syndrom
mer
cov
similar
sarscov
combin
therapi
ribavirin
reduc
viral
replic
sever
histopatholog
chang
line
genet
alter
lead
enhanc
type
ifn
signal
demonstr
limit
iavinduc
diseas
outcom
recent
studi
xing
et
al
report
delet
neg
regul
nemo
lead
induct
therefor
enhanc
type
ifn
product
protect
vivo
iavinfect
mice
convers
genet
deplet
ifn
signal
ifn
receptordefici
mice
result
lack
viral
control
result
enhanc
viral
titer
differ
viral
infect
includ
rsv
iav
still
must
note
effect
often
mild
ifnar
ifnlrdefici
anim
probabl
relat
certain
redund
type
type
iii
ifn
signal
limit
viral
spread
epitheli
cell
contrast
ifnarifnlrdoubl
knockout
knockout
anim
defici
type
type
iii
ifn
signal
transduct
succumb
readili
infect
due
excess
viral
replic
vice
versa
mutat
key
isg
associ
increas
iav
diseas
sever
mice
human
howev
ifn
pretreat
genet
lossoffunct
approach
gener
relev
human
respiratori
virusinduc
hospit
patient
alreadi
present
ongo
respiratori
infect
inflamm
preclin
studi
underlin
type
ifn
signal
alreadi
inflam
organ
rather
detriment
enhanc
tissu
injuri
lack
type
ifn
vivo
may
even
amelior
diseas
outcom
accordingli
case
antivir
defens
compromis
eg
anim
effici
type
iii
ifn
signal
ifnardefici
mice
infect
sendai
viru
iav
report
resist
infectioninduc
morbid
mortal
similarli
sendai
viru
vivo
infect
wetzel
et
al
show
increas
level
lung
homogen
correl
increas
morbid
mortal
also
sarscov
recent
studi
demonstr
high
type
ifn
induct
alreadi
ongo
viral
infect
contribut
mortal
sarscovinfect
mice
also
iav
infect
type
ifn
applic
infect
proven
drive
diseas
sever
note
detriment
effect
type
ifn
especi
pronounc
mice
lack
central
antivir
factor
name
ifit
protein
sendai
viru
infect
mxa
iav
interestingli
beilharz
et
al
demonstr
applic
low
dose
reduc
viral
load
certain
degre
led
attenu
diseas
progress
wherea
high
dose
applic
type
ifn
contribut
morbid
line
high
express
level
isg
shown
correl
wors
outcom
ard
patient
observ
correspond
report
state
ifn
threshold
need
induc
antivir
benefici
effect
acut
respiratori
viral
least
lower
ifn
dose
necessari
trigger
isg
show
immunomodulatori
deathinduc
antiprolif
effect
thu
contribut
diseas
progress
altogeth
data
demonstr
ifn
may
significantli
contribut
unbalanc
inflamm
tissu
injuri
respiratori
viral
infect
depend
express
level
durat
ifnrel
signal
event
date
underli
mechan
lead
ifndepend
enhanc
diseas
progress
fulli
understood
often
result
dysregul
ifn
signal
respons
one
mode
action
ifn
ifnstimul
isg
stimul
neg
feedback
loop
ifn
signal
exampl
suppress
via
specif
phosphatas
express
suppressor
cytokin
signal
soc
ubiquitin
endocytosi
ifn
receptor
desensit
cell
ifn
signal
allow
recoveri
return
homeostasi
microbi
challeng
demonstr
bhattacharya
et
al
lack
ifnar
downregul
thu
failur
initi
ifndesensit
contribut
increas
inflammatori
signal
extens
lung
injuri
importantli
also
impair
tissu
regener
moreov
ifn
immunomodulatori
shape
specif
respons
cell
immun
system
impli
influenc
diseas
progress
posit
neg
recent
studi
type
ifn
associ
regul
innat
lymphoid
immun
cell
ilc
iav
infect
concert
restrict
immunopatholog
moreov
type
ifn
play
import
role
stimul
immun
respons
driven
dc
stimul
express
mhc
molecul
well
costimulatori
ligand
thu
activ
cell
respons
addit
liganddriven
activ
ifnar
enhanc
prolifer
posit
cell
especi
earli
infect
howev
late
infect
type
ifn
also
impli
decreas
cell
expans
upon
sarscov
arenaviru
infect
might
potenti
relat
describ
desensit
upon
prolong
ifn
signal
might
detriment
initi
earli
infect
line
pinto
et
al
report
impair
cell
respons
upon
type
ifn
induct
west
nile
viru
infect
b
cell
lack
ifnar
demonstr
result
enhanc
releas
neutral
antibodi
iav
infect
impli
repress
role
type
ifn
b
cell
antibodi
product
howev
immun
studi
le
bon
et
al
report
necess
ifnar
b
cell
effici
igm
igg
product
underlin
need
studi
understand
detail
effect
ifndosag
time
adapt
immun
activ
upon
respiratori
viral
infect
type
ifn
addit
induc
product
high
level
proinflammatori
cytokin
close
link
worsen
outcom
acut
respiratori
viral
infect
especi
iav
diseas
sever
diseas
progress
link
overshoot
ifndriven
inflammatori
respons
exogen
supplement
type
ifn
fact
correl
increas
morbid
mortal
nonhuman
primat
iav
infect
highli
pathogen
isol
evok
strong
induct
type
ifn
result
sever
lung
injuri
necrot
bronchiol
alveoloti
ifn
level
turn
demonstr
caus
elev
proinflammatori
cytokin
level
vivo
iav
infect
addit
human
alveolar
macrophag
releas
proinflammatori
cytokin
eg
preced
robust
type
ifn
respons
importantli
also
human
infect
level
proinflammatori
cytokin
strongli
elev
bronchoalveolar
lavag
fluid
cytokin
level
associ
organ
damag
worsen
diseas
outcom
still
note
due
strain
differ
viruselicit
prr
activ
importantli
ifn
antagon
iav
nonstructur
ns
protein
ifn
level
diseas
sever
alway
directli
correl
actual
extent
suppress
ifn
respons
relat
prolong
viremia
thu
also
determin
viru
pathogen
human
bronchial
epitheli
cell
vivo
model
iav
infect
alongsid
iav
also
rsv
infect
induct
high
level
proinflammatori
cytokin
directli
relat
type
ifn
rsvinfect
ifnardefici
mice
present
significantli
diminish
proinflammatori
cytokin
releas
translat
attenu
diseas
cours
also
sarscov
late
phase
type
ifn
induct
relat
accumul
inflammatori
macrophag
popul
elev
lung
cytokin
level
addit
antivir
immunomodulatori
proinflammatori
isg
ifn
signal
result
transcript
translat
cell
deathinduc
isg
context
viral
infect
factor
provid
mode
block
viral
spread
reinfect
kill
infect
cell
intern
activ
antivir
isg
suffici
restrict
viral
replic
thu
infect
cell
sacrif
prevent
releas
infecti
progeni
virion
limit
viral
spread
howev
especi
lung
disrupt
alveolar
epitheli
barrier
cell
death
infect
cell
importantli
also
noninfect
bystand
cell
induc
factor
trail
significantli
contribut
worsen
diseas
outcom
control
cell
death
apoptosi
induc
intrins
extrins
signal
intrins
apoptosi
pathway
initi
divers
intracellular
stimuli
influenc
express
activ
b
cell
lymphoma
bcl
famili
protein
govern
permeabil
statu
outer
mitochondri
membran
cytochrom
c
releas
mitochondria
bind
intracellular
adaptor
protein
apoptot
peptidas
activ
factor
form
socal
apoptosom
turn
recruit
caspas
cysteineaspart
proteas
exert
action
cleav
protein
substrat
herein
initi
caspas
target
downstream
caspas
wherea
effector
caspas
includ
directli
caus
apoptosi
cleav
thu
inactiv
disassembl
vast
array
cellular
integr
protein
complex
extrins
apoptosi
pathway
reli
extracellular
signal
exert
ligand
tumor
necrosi
factor
tnf
receptor
tnfr
superfamili
includ
trail
fa
ligand
fasl
ligat
respect
cell
surfaceexpress
death
receptor
dr
lead
via
signal
transmiss
fasassoci
protein
death
domain
fadd
activ
initi
final
stimul
effector
caspas
includ
date
sever
type
type
iii
ifninduc
proapoptot
factor
identifi
shown
upregul
upon
type
ifn
signal
enhanc
fadddriven
extrins
apoptosi
pathway
wherea
lessstudi
may
promot
cleavag
inflammasomedriven
cell
death
pyroptosi
macrophag
chattopadhyay
et
al
demonstr
sendai
viru
infect
polyi
c
treatment
result
x
protein
bax
activ
apoptosi
induct
via
one
key
transcript
factor
ifn
gene
addit
report
enhanc
traildepend
extrins
apoptosi
nuclear
transloc
result
translat
date
undefin
factor
increas
cell
death
upstream
activ
furthermor
rlr
rigi
trigger
protein
puma
noxa
induc
bcl
thu
activ
intrins
mitochondri
apoptot
cascad
also
pkr
influenc
cell
suscept
apoptot
signal
demonstr
sensit
apoptosi
pathway
upon
type
ifn
signal
challeng
iav
dsrna
oasrnasel
system
suggest
contribut
cell
death
induct
exact
mechan
remain
elucid
final
also
two
classic
initi
extrins
apoptosi
cascad
induc
isg
fasl
receptor
fa
upregul
mrna
level
fasl
report
induc
type
ifn
iav
infect
murin
lung
vivo
also
proapoptot
factor
trail
induc
ifnmedi
transcript
activ
shown
sato
et
al
reveal
presenc
isr
sequenc
within
trail
promot
region
iav
infect
trail
releas
high
amount
infect
alveolar
macrophag
depend
pkr
autocrin
signal
loop
bind
macrophageexpress
ifnar
activ
jakstatdepend
releas
trail
act
receptor
alveolar
epitheli
cell
howev
certain
prerequisit
may
decreas
abil
cell
undergo
apoptosi
includ
shortag
avail
express
cellular
faddlik
enzymeinhibitori
protein
cflip
block
fadddriven
caspas
activ
inactiv
degrad
fadd
express
cyld
act
receptorinteract
serinethreonineprotein
rip
kinas
deubiquitinas
thu
stabil
howev
case
ifn
signal
still
promot
caspaseindepend
program
inflammatori
cell
death
activ
necroptosi
pathway
necroptosi
induc
complex
format
kinas
activ
polyadpribos
par
polymeras
andor
mix
lineag
kinas
domainlik
mlkl
lead
atp
deplet
calpain
activ
par
polym
accumul
cell
membran
permeabil
releas
damageassoci
molecular
pattern
respect
review
ref
type
ifndepend
jakstatdriven
activ
pkr
well
signal
prr
dai
dnadepend
activ
irf
initi
necroptosi
via
activ
respect
importantli
activ
proapoptot
pronecroptot
pathway
respiratori
infect
result
structur
disrupt
airway
alveolar
epitheli
barrier
major
hallmark
respiratori
diseas
progress
acut
respiratori
distress
syndrom
virusinduc
lung
injuri
especi
express
trail
initi
apoptosi
well
necroptosi
correl
sever
outcom
describ
earlier
trail
belong
superfamili
tnf
ligand
report
induc
type
type
iii
ifn
trail
found
present
variou
cell
immun
system
among
natur
killer
nk
cell
cell
nk
cell
dc
subset
killer
dc
macrophag
display
larg
amount
cell
surfac
shed
upon
ifn
andor
proinflammatori
cytokin
signal
addit
cell
immun
system
fibroblast
shown
produc
trail
treatment
viral
challeng
also
club
cell
alveolar
epithelium
report
produc
trail
similar
ligand
tnf
superfamili
trail
homotrimer
type
ii
transmembran
protein
conserv
ctermin
extracellular
domain
mediat
receptor
bind
cleav
metalloproteinas
gener
solubl
mediat
howev
trail
induc
cell
death
also
membranebound
form
similar
trail
express
level
trail
shed
upregul
type
ifn
direct
celltocel
interact
demonstr
play
role
macrophag
nk
well
cellmedi
induct
cellular
death
human
five
differ
bind
partner
trail
present
membranebound
induc
proapoptot
signal
cascad
membranebound
antiapoptot
decoy
receptor
dcr
solubl
interact
partner
osteoprotegerin
murin
system
identifi
ligat
trail
human
respiratori
compart
demonstr
present
steadyst
condit
howev
upon
viral
infect
cellsensit
trailinduc
apoptosi
enhanc
attribut
increas
trail
receptor
express
especi
infect
cell
dr
level
markedli
increas
iav
adenoviru
paramyxovirusinfect
cell
contrast
noninfect
bystand
cell
note
studi
depend
dr
upregul
upon
type
ifn
signal
iav
infect
yield
conflict
result
differ
strain
mice
highlight
complex
interplay
ifninduc
cascad
host
tissuespecif
context
wherea
exact
viru
hostspecif
mechan
dr
regul
remain
less
well
defin
moreov
previou
assumpt
also
dcr
express
would
correl
cellsensit
trailinduc
cell
death
could
experiment
verifi
tumor
necrosi
factorrel
apoptosisinduc
ligand
ligat
proapoptot
receptor
trigger
trimer
receptor
subsequ
depend
addit
stimuli
presenc
absenc
adaptor
molecul
inhibitori
protein
differ
signal
pathway
activ
figur
classic
traildepend
extrins
apoptosi
induct
protein
rip
tradd
fadd
subsequ
recruit
dr
cytoplasm
domain
upon
trail
ligat
factor
proapoptot
dr
share
cytoplasm
death
domain
dd
lack
truncat
thu
inact
dcr
dd
play
central
role
concert
format
deathinduc
signal
complex
disc
disc
format
expos
second
function
domain
fadd
death
effector
domain
directli
abl
recruit
exactli
disc
format
induc
caspas
activ
still
debat
probabl
scenario
includ
either
autocatalyt
cleavag
caspaseprodomain
enabl
spatial
proxim
procaspas
gener
recruit
disc
procaspas
dimer
procaspas
conform
stabil
remov
prodomain
result
activ
effector
cleav
dna
fragment
factor
lead
apoptosi
moreov
trailbind
induc
jnk
either
via
recruit
tnf
receptorassoci
protein
disc
complex
result
activ
intrins
apoptot
cascad
baxdepend
mitochondri
cytochrom
c
releas
addit
trail
signal
also
abl
induc
necroptosi
activ
kinas
downstream
effector
mlkl
contribut
epitheli
cell
death
tissu
injuri
becom
appar
recent
year
trail
signal
close
link
induct
autophagi
process
gener
associ
blockad
apoptosi
necrosi
inde
autophagi
report
improv
cellular
surviv
cell
stress
catabol
remov
cytoplasm
longliv
protein
damag
organel
also
contribut
viral
clearanc
transfer
viral
materi
endosomallysosomalloc
mhc
class
ii
compart
activ
adapt
immun
sever
studi
outlin
trail
ligat
result
activ
attribut
central
role
trailinduc
autophagi
activ
modul
ikkdepend
transloc
also
induc
jnk
activ
via
mitogenactiv
protein
kinas
event
lead
express
autophagyrel
factor
includ
inhibit
autophag
machineri
ciap
xlink
inhibitor
apoptosi
protein
cflip
especi
cflip
associ
desensit
cell
trailinduc
apoptosi
favor
autophagyrel
cascad
anoth
studi
reveal
upon
trail
signal
ampactiv
protein
kinas
ampk
activ
ampk
turn
inhibit
mammalian
target
rapamycin
complex
inhibitor
autophagi
thu
activ
autophag
machineri
promot
decis
trail
signal
result
rather
necroptot
apoptot
cell
death
activ
autophagi
seem
depend
presenc
ciap
promot
rip
kinas
ubiquitin
degrad
also
balanc
activ
caspas
autophag
protein
suggest
scenario
autophagi
activ
cell
protect
mechan
cell
execut
enhanc
trail
signal
addit
viral
threshold
favor
cell
death
induct
accordingli
trail
signal
restrict
infect
cell
excess
cell
death
activ
might
limit
autophagi
induct
noninfect
bystand
cell
howev
autophagi
relat
cell
surviv
also
posit
affect
apoptosi
exact
mechan
still
autophagyrel
cell
death
anoth
mode
trail
trigger
cell
death
note
autophagi
activ
need
place
virusspecif
context
virus
includ
dengu
viru
polioviru
coxsacki
b
viru
exploit
autophag
pathway
replic
thu
promot
apoptosi
tissu
injuri
releas
effect
trail
especi
well
studi
iav
infect
last
decad
earlier
studi
report
within
day
infect
bronchial
bronchiolar
alveolar
epitheli
cell
undergo
apoptosi
earli
induct
cell
death
mainli
attribut
direct
apoptosi
induct
viru
iav
activ
promot
apoptosi
effici
viral
replic
herein
viral
protein
play
crucial
role
also
viral
protein
implic
process
inhibit
autophagi
infect
cell
addit
data
reveal
later
iav
vivo
infect
recruit
bone
marrowderiv
macrophag
via
cc
chemokin
receptor
type
ligand
axi
significantli
contribut
alveolar
cell
apoptosi
structur
damag
alveolar
epithelium
studi
wurzer
et
al
previous
demonstr
iav
promot
product
proapoptot
factor
auto
paracrin
fashion
via
transcript
activ
iav
subsequ
brinck
et
al
elucid
human
peripher
blood
mononuclear
cell
treat
iav
releas
trail
increas
trail
level
correl
type
well
ii
ifn
induct
addit
trail
sensit
increas
influenza
virusinfect
cell
line
investig
could
elucid
iav
trigger
pkrdepend
transloc
result
product
type
ifn
turn
induc
via
ligat
ifnar
receptor
complex
express
shed
trail
bone
marrowderiv
macrophag
addit
davidson
et
al
demonstr
type
ifn
applic
iavinfect
mice
increas
morbid
lung
injuri
could
attribut
trail
upregul
induc
epitheli
cell
apoptosi
importantli
et
al
also
report
iav
strain
use
studi
highli
pathogen
mice
induc
approxim
induct
macrophag
trail
express
wherea
lower
pathogen
viru
stimul
trail
factor
eight
note
relat
trail
induct
iav
strainspecif
pathogen
also
translat
highli
pathogen
avian
iav
caus
sever
pneumonia
mice
well
human
moreov
human
infect
highli
pathogen
well
pandem
iav
strain
character
massiv
influx
mononuclear
phagocyt
alveoli
correl
extens
alveolar
epitheli
cell
apoptosi
addit
macrophag
gain
bronchoalveolar
lavag
patient
present
ard
caus
pandem
viru
strain
show
high
surfac
express
releas
trail
anoth
recent
report
demonstr
highli
pathogen
avian
influenza
addit
macrophag
also
alveolar
epithelium
might
involv
caus
elev
level
trail
alveolar
space
besid
role
apoptosi
trail
signal
upon
iav
infect
also
implic
induct
necroptosi
fibroblast
dc
lung
epitheli
cell
rodriguegervai
et
al
demonstr
lack
promot
kinasemedi
necroptosi
respons
also
proapoptot
factor
hematopoiet
cell
contribut
sever
lung
epitheli
degener
increas
mortal
even
though
viral
control
compromis
nogusa
et
al
elucid
iavinduc
necroptosi
depend
kinas
activ
mlkl
kinas
defici
similar
increas
iavsuscept
vivo
iav
infect
mention
earlier
express
elev
infect
alveolar
epitheli
cell
noninfect
cell
vivo
might
impact
trail
suscept
apoptosi
induct
howev
infect
well
neighbor
bystand
cell
found
target
apoptosi
induct
macrophagereleas
trail
nonetheless
could
recent
show
specif
noninfect
cell
within
iavinfect
lung
trail
sever
compromis
function
ion
channel
na
katpas
mediat
via
induct
stress
kinas
ampk
therebi
potenti
reveal
crosslink
trailinduc
autophag
cell
stress
pathway
bystand
cell
vitro
vivo
trailinduc
ampkmedi
downregul
na
katpas
major
driver
vertic
ion
fluid
transport
alveolar
airspac
toward
interstitium
result
reduc
capac
iavinfect
mice
clear
excess
fluid
alveoli
thu
trail
signal
contribut
intens
edema
format
hallmark
diseas
virusinduc
ard
notabl
effect
trail
na
katpas
express
induc
independ
cell
death
pathway
elicit
caspas
treatment
cell
mice
specif
inhibitor
diminish
apoptosi
alveolar
epitheli
cell
still
allow
reduct
na
katpas
conclus
treatment
iavinfect
mice
neutral
antibodi
direct
trail
abrog
recruit
trail
bone
marrowderiv
macrophag
inhibit
apoptosi
noninfect
bystand
cell
thu
lung
leakag
due
loss
alveolar
barrier
function
reduc
wherea
alveolar
fluid
clearanc
capac
enhanc
result
reduc
edema
improv
surviv
outcom
upon
iav
challeng
vivo
howev
trail
also
shown
upregul
nk
dc
cell
iav
infect
studi
brinck
et
al
demonstr
especi
involv
cytotox
cell
respons
toward
iav
drive
iavinfect
cell
apoptosi
via
trail
thu
contribut
effici
viru
clearanc
addit
fasl
trail
involv
dcmediat
ctl
activ
cytotox
iavinfect
cell
furthermor
studi
show
delay
viral
clearanc
upon
neutral
antitrail
antibodi
administr
data
howev
demonstr
transfer
traildefici
bone
marrow
irradi
wildtyp
mice
result
loss
trail
product
bone
marrowderiv
macrophag
upon
iav
infect
impact
capac
fulli
clear
viral
particl
lung
day
infect
suggest
compensatori
mechan
recruit
guarante
viral
clearanc
taken
togeth
iav
infect
trail
act
import
mediat
infect
cell
kill
particularli
detriment
factor
contribut
tissu
injuri
impair
inflamm
resolut
releas
excess
amount
recruit
immun
cell
respiratori
syncyti
viru
import
caus
respiratori
tract
infect
especi
children
worldwid
gener
seem
viruselicit
antiapoptot
mechan
activ
lung
epithelium
rsvinfect
primari
human
airway
cell
show
minim
cytopath
effect
howev
sever
cell
line
includ
small
airway
cell
primari
trachealbronchi
cell
show
increas
express
trail
ligand
vitro
rsv
infect
model
moreov
solubl
trail
releas
leukocyt
elev
bronchoalveolar
lavag
fluid
patient
rsvassoci
respiratori
failur
suggest
similar
iav
trail
contribut
rsvinduc
epitheli
injuri
diseas
progress
also
cov
respiratori
tract
infect
trail
level
less
fasl
report
markedli
elev
sarscov
present
sever
damag
upper
lower
respiratori
tract
especi
dc
respond
strong
induct
trail
product
suggest
correl
increas
cellular
lung
infiltr
present
sarscov
patient
interestingli
sarscov
infect
drive
cell
apoptosi
pkrdriven
pathway
seen
iav
pkrinduc
autocrineparacrin
execut
activ
apoptosi
also
merscov
caus
pneumonia
respiratori
failur
demonstr
induc
profound
cell
death
within
h
infect
irrespect
viral
titer
produc
infect
cell
howev
type
ifn
express
strongli
reduc
merscov
comparison
season
human
cov
vitro
infect
model
includ
human
monocytederiv
macrophag
human
lung
fibroblast
might
also
dampen
downstream
trail
induct
therefor
exact
mechan
merscov
promot
cell
death
remain
investig
recurr
viral
infect
respiratori
tract
follow
outgrowth
colon
gramposit
bacteria
aggrav
cours
ill
well
document
iav
super
infect
streptococcu
pneumonia
staphylococcu
aureu
frequent
increas
viral
pneumoniaassoci
morbid
mortal
iav
pandem
bacteri
pneumonia
evid
case
also
recent
pandem
coinfect
relev
factor
sever
diseas
young
patient
popul
without
comorbid
interestingli
virusinduc
elev
type
ifn
respons
level
might
promot
secondari
bacteri
outgrowth
sever
mechan
review
ref
line
repeatedli
demonstr
lack
type
ifn
signal
result
better
bacteri
clearanc
increas
surviv
rate
iav
pneumoniaesuperinfect
mice
herein
ifninduc
apoptosi
induct
well
deplet
impair
recruit
lymphocyt
subset
necessari
bacteri
control
play
critic
role
bacteri
clearanc
lung
report
reli
suffici
phagocyt
gener
recruit
surviv
type
ifn
demonstr
caus
apoptosi
bone
marrowderiv
granulocyt
affect
number
recruit
neutrophil
also
impair
express
cytokin
kc
thu
inhibit
neutrophil
recruit
lung
sever
effect
surviv
superinfect
mice
recent
report
schlieh
et
al
elucid
mechanist
background
impair
express
secret
demonstr
type
ifn
activ
histon
methyltransferas
turn
repress
promot
thu
impair
neutrophil
recruit
bacteri
clearanc
moreov
type
ifn
product
decreas
product
thu
inhibit
macrophag
recruit
well
report
detriment
effect
bacteri
clearanc
diseas
progress
bacteri
superinfect
viral
insult
vivo
addit
type
ifn
also
impair
cell
function
releas
shown
increas
suscept
pneumonia
superinfect
iav
challeng
also
aureu
pneumonia
robust
type
ifn
respons
correl
excess
morbid
tissu
injuri
model
polyi
c
aureu
methicillinresist
strain
mrsa
superinfect
polyi
c
treatment
prior
bacteri
infect
enhanc
type
ifn
level
decreas
bacteri
clearanc
surviv
furthermor
shepardson
et
al
demonstr
late
type
ifn
induct
render
mice
suscept
secondari
bacteri
pneumonia
model
superinfect
limit
data
avail
direct
role
trail
respiratori
diseas
progress
due
bacteri
superinfect
model
influenza
infect
neither
defici
cc
chemokin
receptor
type
inhibit
bone
marrowderiv
macrophag
recruit
defici
fa
impact
outcom
yet
pneumonia
singl
infect
earli
cell
death
macrophag
thought
limit
exuber
inflammatori
reaction
accordingli
studi
steinwed
et
al
reveal
neutrophilderiv
trail
limit
tissu
injuri
induc
cell
death
lung
macrophag
bacteri
monoinfect
contrast
pneumonia
superinfect
mous
model
iavinduc
trail
detriment
effect
overal
mortal
trailinduc
epitheli
injuri
enhanc
bacteri
outgrowth
day
iav
importantli
administr
antitrail
neutral
antibodi
enhanc
bacteri
control
host
organ
thu
activ
ifntrailmedi
signal
viral
infect
detriment
implic
outcom
secondari
bacteri
infect
follow
viral
insult
render
ifntrail
signal
axi
interest
therapeut
target
respiratori
viral
infect
also
complic
bacteri
superinfect
increas
number
report
connect
progress
chronic
respiratori
diseas
acut
respiratori
viru
infect
proapoptot
signal
event
fact
trail
report
critic
determin
promot
develop
chronic
lung
diseas
earli
life
target
trail
genet
delet
neutral
antibodi
applic
earlylif
respiratori
infect
amelior
infectioninduc
histopatholog
inflamm
well
emphysemalik
alveolar
enlarg
lung
function
furthermor
trail
also
shown
play
role
develop
allergi
asthma
trail
elev
sputum
asthmat
patient
also
report
highli
express
experiment
mous
model
asthma
induc
secret
bronchial
epitheli
cell
thu
promot
cell
respons
airway
hyperreact
copd
acut
exacerb
driven
viral
bacteri
infect
major
factor
increas
mortal
morbid
influenza
pneumonia
identifi
among
common
caus
copd
exacerb
inde
primari
bronchial
epitheli
cell
isol
subject
copd
show
impair
product
type
ifn
impli
enhanc
suscept
copd
patient
respiratori
infect
howev
even
absenc
high
ifn
induct
abnorm
elev
loss
alveolar
epitheli
cell
due
apoptosi
well
elev
trail
level
report
impli
possibl
link
viralbacteri
induct
trail
acut
exacerb
copd
trail
induct
also
directli
link
cigarettesmok
exposur
common
caus
copd
trail
defici
result
decreas
pulmonari
inflamm
emphysemalik
alveolar
enlarg
vivo
moreov
increas
level
trail
associ
impair
lung
function
increas
system
inflamm
human
copd
patient
alveolar
epitheli
cell
death
close
connect
idiopath
pulmonari
fibrosi
ipf
trail
receptor
aec
shown
upregul
ipf
lung
also
pulmonari
arteri
hypertens
viru
infect
consid
possibl
risk
factor
pulmonari
hypertens
report
side
effect
prolong
treatment
type
ifn
line
trail
close
link
diseas
progress
pulmonari
hypertens
trail
found
increas
within
pulmonari
vascular
lesion
patient
pulmonari
hypertens
also
mous
model
hypoxiainduc
pulmonari
hypertens
level
solubl
trail
correl
right
ventricular
systol
pressur
right
ventricular
hypertrophi
patholog
alter
importantli
neutral
antibodytreat
trail
show
posit
effect
surviv
reduc
pulmonari
vascular
remodel
notabl
extent
infectioninduc
trail
releas
caus
exacerb
chronic
lung
diseas
far
trail
product
chronic
lung
diseas
affect
suscept
respiratori
viral
complic
bacteri
infect
remain
elucid
respiratori
viral
infect
major
caus
agent
lung
injuri
ard
howev
mani
case
antivir
suffici
limit
diseas
besid
fact
virus
subject
strong
select
pressur
favor
quickli
evolv
drugresist
viru
variant
recent
advanc
understand
process
contribut
tissu
injuri
ard
highlight
crucial
role
immunerel
ifndriven
event
therefor
novel
therapeut
strategi
often
aim
improv
outcom
sever
respiratori
infect
modul
host
cell
respons
howev
date
clinic
trial
tri
improv
sever
viral
infect
ard
outcom
target
host
pathway
result
approv
new
drug
note
establish
therapi
consid
time
intens
induct
amplif
well
dampen
termin
ifndriven
immun
respons
need
precis
match
pathogen
organspecif
requir
given
infect
noncontrol
regul
process
may
lead
either
unrestrict
pathogen
spread
extrem
overshoot
inflammatori
respons
includ
increas
product
proinflammatori
proapoptot
mediat
elev
level
recruit
immun
cell
andor
aberr
repair
process
notabl
low
high
level
ifninduc
effect
facilit
diseas
progress
possibl
increas
fatal
outcom
ard
patient
accordingli
preclin
vivo
studi
ifndirect
therapi
yield
seemingli
advers
result
depend
context
time
dosag
ifn
modul
howev
multipl
set
acut
respiratori
viral
infect
studi
demonstr
exagger
signal
deriv
type
ifn
alreadi
inflam
tissu
contribut
worsen
outcom
importantli
might
favor
secondari
bacteri
superinfect
eg
ref
interestingli
davidson
et
al
demonstr
type
iii
ifn
releas
upon
influenza
contrast
type
ifn
trigger
unbalanc
inflammatori
respons
critic
contribut
respiratori
diseas
progress
vivo
highlight
possibl
therapeut
option
iavinduc
lung
injuri
like
effect
deriv
lack
receptor
complex
presenc
ifnar
immun
cell
includ
bone
marrowderiv
macrophag
nonetheless
report
identifi
driver
macrophag
polar
inflammatori
phenotyp
attribut
promot
overshoot
inflammatori
respons
highlight
need
studi
type
iii
ifn
biolog
pathogenassoci
diseas
progress
gener
ifndirect
therapeut
approach
target
variou
downstream
signal
event
might
act
benefici
well
detriment
viral
replic
pathogenesi
approach
address
specif
isg
primarili
show
detriment
effect
diseas
progress
outlin
trail
downstream
signal
event
might
compris
suitabl
target
adjunct
therapi
addit
antivir
accordingli
data
preclin
mous
model
iav
infect
demonstr
clear
benefit
system
applic
neutral
antibodi
trail
day
postinfect
lung
injuri
morbid
mortal
target
trail
major
determin
diseas
sever
respiratori
viral
infect
includ
iav
also
rsv
cov
may
yield
therapeut
approach
superior
ifndirect
strategi
seemingli
bear
risk
compromis
host
defens
yet
thoroughli
exclud
block
trailinduc
cell
death
infect
cell
lead
overwhelm
viral
spread
especi
report
viral
load
upon
trail
inhibit
preclin
model
iav
controversi
accordingli
addit
studi
need
understand
extent
virusinfect
cell
kill
viral
spread
control
mean
absenc
trail
moreov
target
pathway
signal
hub
downstream
traildr
ampk
welltim
lung
compartmentspecif
way
may
open
new
therapeut
avenu
requir
detail
preclin
studi
efficaci
side
effect
valid
approach
might
use
combin
therapi
treatment
togeth
classic
antivir
drug
therapi
limit
viral
replic
howev
exact
dosag
time
kinet
applic
rout
remain
defin
cp
sh
perform
bibliograph
research
draft
manuscript
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
